In Parkinson’s fight, Medtronic’s first-in-the-world adaptive therapy feature wins FDA approval
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
Pharmabiz16h
Medtronic gets US FDA nod for the world’s first adaptive deep brain stimulation system for people with Parkinson’s disease
Medtronic gets US FDA nod for the world’s first adaptive deep brain stimulation system for people with Parkinson’s disease: Galway, Ireland Saturday, March 1, 2025, 09:00 Hrs ...
US FDA approves Medtronic's medical device for Parkinson's disease
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with ...
The American Journal of Managed Care2d
Adaptive Deep Brain Stimulation Technology Receives FDA Approval for Parkinson Disease
The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of ...
Medical Design and Outsourcing4d
A Medtronic engineer shares lessons from the adaptive deep brain stimulation project
The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...
Parkinson’s Patients Have a New Way to Manage Their Symptoms
T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
Modern Healthcare5d
FDA approves Medtronic’s adaptive technology for Parkinson’s
The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available ...
GlobalData on MSN5d
FDA approves Medtronic’s brain stimulation system for Parkinson’s
The FDA’s authorisation of Medtronic’s BrainSense follows the system’s receipt of a CE mark in Europe last month.
medtechdive5d
Medtronic gains FDA OK for self-adjusting DBS system for Parkinson’s
The brain-computer interface technology personalizes therapy based on an individual’s brain activity.
The Business Journals4d
Medtronic gets FDA approval for Brainsense device in Parkinson's patients
Medtronic said Monday the U.S. Food and Drug Administration has approved a brain-stimulation device as a treatment for people with Parkinson's disease, a major milestone for the technology.
MassDevice5d
Medtronic wins first FDA nod for adaptive DBS for Parkinson’s
(NYSE: MDT) announced today that the FDA approved its BrainSense adaptive deep brain stimulation (aDBS) platform.
Medtronic’s BrainSense brain stimulation system approved by FDA for Parkinson’s
Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no cure for debilitating neurological conditions like ...